A revolution in chronic heart failure management and more in CV Directions Vol. 3, No. 1

This is the first and only FDA-approved heart failure monitoring solution proven to reduce heart failure hospital admissions when used by physicians to manage heart failure. And the reduction is significant— 28 percent within the first six months and 37 percent over 15 months demonstrated in a large randomized study...

Learn more about CardioMEMS, find strategies to improve case mix index, or build a learning community in your team through preceptorship—all inside the Alliance of Cardiovascular Professionals flagship, peer-reviewed publication, CV Directions.

Continue reading A revolution in chronic heart failure management and more in CV Directions Vol. 3, No. 1

Has ACVP solved a critical issue facing European medical conferences?

Thanks to the recent adoption of a new code of ethical conduct by MedTech Europe, a group of industry associations doing business in Europe, the future of European cardiology conferences may soon be in jeopardy.

The reason? More barriers to attendance.

It’s not that these conferences suffer from a lack of interested medical professionals. It’s just that, while many MDs would very much like to attend, registering for a cardiology conference in Europe is not cheap—on the order of thousands of dollars per event.

Everybody, the attendees, the presenters, with the exception of a very limited number of senior professors, has to pay, and it is understood that the physicians will attend more than a few over the course of a year.

And, in the time honored tradition of using off-site attractions as a lure for good registration numbers, the meetings are held in “not cheap” locations across the Continent, further ballooning the cost of attendance.

Continue reading Has ACVP solved a critical issue facing European medical conferences?

ICYMI: TAVR Out-Performs Surgical Replacement

This video from Diagnostic and Interventional Cardiology's Pulse TV shares the biggest piece of news from the American College of Cardiology's annual conference last month---that Transcatheter Aortic Valve Replacement (TAVR) out-performed surgical valve replacement in the PARTNER II trial.

Continue reading ICYMI: TAVR Out-Performs Surgical Replacement

Interprofessional Cardiovascular Education – Essential Characteristic #4

Is your team a learning community? Try interprofessional cardiovascular education.

interprofessional cardiovascular education

We're still counting our five essential characteristics for highly effective cardiac care teams. Number four? Interprofessional cardiovascular education.

ACVP Blog recently discussed the ACC's Health Policy Statement advocating for team-based care.

In that statement, the authors also detailed the importance of interprofessional cardiovascular education in facilitating team-based care and communication, another one of our essential characteristics for highly effective cardiovascular teams.

Continue reading Interprofessional Cardiovascular Education – Essential Characteristic #4